High-fat diet intensifies MLL-AF9-induced acute myeloid leukemia through activation of the FLT3 signaling in mouse primitive hematopoietic cells.

Date publication

septembre 2020

Journal

Scientific reports

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CALLIER Patrick , Dr DELVA Laurent , Dr HERMETET François , Dr QUERE Ronan

Tous les auteurs :
Hermetet F, Mshaik R, Simonet J, Callier P, Delva L, Quéré R

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32999332

Résumé

Using a MLL-AF9 knock-in mouse model, we discovered that consumption of a high-fat diet (HFD) accelerates the risk of developing acute myeloid leukemia (AML). This regimen increases the clusterization of FLT3 within lipid rafts on the cell surface of primitive hematopoietic cells, which overactivates this receptor as well as the downstream JAK/STAT signaling known to enhance the transformation of MLL-AF9 knock-in cells. Treatment of mice on a HFD with Quizartinib, a potent inhibitor of FLT3 phosphorylation, inhibits the JAK3/STAT3, signaling and finally antagonizes the accelerated development of AML that occurred following the HFD regimen. We can therefore conclude that, on a mouse model of AML, a HFD enforces the FLT3 signaling pathway on primitive hematopoietic cells and, in turn, improves the oncogenic transformation of MLL-AF9 knock-in cells and the leukemia initiation.